- #ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six monthsThe race to be third to market with an obesity pill has a number of contenders, including Roche, Pfizer and Structure Therapeutics. On Monday, AstraZeneca set out its own stall with data on a pill ...Endpoints · 1mo ago↗ source
- Incyte CEO sees $2B Vega deal aiding a post-Jakafi futureBill Meury has been in or led the C-suite of several biopharma companies that have constructed multibillion-dollar exits over the past decade: Allergan, Karuna and Anthos. Now, he’s the one buyin…Endpoints · 1mo ago↗ source
- City Therapeutics gets $99M to gather data on three RNAi medicinesCity Therapeutics, the next-gen RNAi startup founded and led by former Alnylam executives, has collected $99.5 million to fund the clinical development of its first three candidates and expand into…